vs

Side-by-side financial comparison of Outset Medical, Inc. (OM) and SMITH MIDLAND CORP (SMID). Click either name above to swap in a different company.

Outset Medical, Inc. is the larger business by last-quarter revenue ($28.9M vs $23.1M, roughly 1.2× SMITH MIDLAND CORP). SMITH MIDLAND CORP runs the higher net margin — 9.2% vs -67.5%, a 76.7% gap on every dollar of revenue. On growth, SMITH MIDLAND CORP posted the faster year-over-year revenue change (24.7% vs -2.0%). Over the past eight quarters, SMITH MIDLAND CORP's revenue compounded faster (17.4% CAGR vs 1.2%).

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

Smith Midland Corp is a specialized manufacturer of precast concrete products for infrastructure, commercial, residential and industrial construction uses. Its key product lines include highway safety barriers, acoustic sound walls, architectural precast panels, and stormwater management systems, serving primarily the North American market with durable, sustainable construction solutions.

OM vs SMID — Head-to-Head

Bigger by revenue
OM
OM
1.2× larger
OM
$28.9M
$23.1M
SMID
Growing faster (revenue YoY)
SMID
SMID
+26.7% gap
SMID
24.7%
-2.0%
OM
Higher net margin
SMID
SMID
76.7% more per $
SMID
9.2%
-67.5%
OM
Faster 2-yr revenue CAGR
SMID
SMID
Annualised
SMID
17.4%
1.2%
OM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OM
OM
SMID
SMID
Revenue
$28.9M
$23.1M
Net Profit
$-19.5M
$2.1M
Gross Margin
42.4%
57.5%
Operating Margin
-61.1%
37.8%
Net Margin
-67.5%
9.2%
Revenue YoY
-2.0%
24.7%
Net Profit YoY
24.0%
52.5%
EPS (diluted)
$0.33
$0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OM
OM
SMID
SMID
Q4 25
$28.9M
$23.1M
Q3 25
$29.4M
$21.5M
Q2 25
$31.4M
$26.2M
Q1 25
$29.8M
$22.7M
Q4 24
$29.5M
$18.5M
Q3 24
$28.7M
$23.6M
Q2 24
$27.4M
$19.6M
Q1 24
$28.2M
$16.8M
Net Profit
OM
OM
SMID
SMID
Q4 25
$-19.5M
$2.1M
Q3 25
$-17.8M
$2.9M
Q2 25
$-18.5M
$4.2M
Q1 25
$-25.8M
$3.3M
Q4 24
$-25.6M
$1.4M
Q3 24
$-27.9M
$3.1M
Q2 24
$-34.5M
$2.0M
Q1 24
$-39.9M
$1.1M
Gross Margin
OM
OM
SMID
SMID
Q4 25
42.4%
57.5%
Q3 25
39.4%
26.8%
Q2 25
37.8%
0.0%
Q1 25
37.2%
30.7%
Q4 24
36.5%
51.4%
Q3 24
34.3%
27.9%
Q2 24
35.7%
0.0%
Q1 24
29.2%
23.3%
Operating Margin
OM
OM
SMID
SMID
Q4 25
-61.1%
37.8%
Q3 25
-53.7%
18.0%
Q2 25
-53.7%
0.0%
Q1 25
-55.1%
19.3%
Q4 24
-74.2%
24.5%
Q3 24
-83.2%
16.3%
Q2 24
-112.3%
0.0%
Q1 24
-131.0%
9.0%
Net Margin
OM
OM
SMID
SMID
Q4 25
-67.5%
9.2%
Q3 25
-60.6%
13.4%
Q2 25
-59.0%
15.9%
Q1 25
-86.7%
14.7%
Q4 24
-87.0%
7.5%
Q3 24
-97.5%
13.4%
Q2 24
-125.8%
10.1%
Q1 24
-141.8%
6.8%
EPS (diluted)
OM
OM
SMID
SMID
Q4 25
$0.33
$0.41
Q3 25
$-1.00
$0.54
Q2 25
$-1.04
$0.79
Q1 25
$-3.66
$0.62
Q4 24
$-7.21
$0.28
Q3 24
$-8.02
$0.59
Q2 24
$-9.96
$0.37
Q1 24
$-11.77
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OM
OM
SMID
SMID
Cash + ST InvestmentsLiquidity on hand
$168.9M
Total DebtLower is stronger
$96.2M
Stockholders' EquityBook value
$127.0M
$54.3M
Total Assets
$264.5M
$87.7M
Debt / EquityLower = less leverage
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OM
OM
SMID
SMID
Q4 25
$168.9M
Q3 25
$178.6M
Q2 25
$184.1M
Q1 25
$189.0M
Q4 24
$158.7M
Q3 24
$175.6M
Q2 24
$194.8M
Q1 24
$226.9M
Total Debt
OM
OM
SMID
SMID
Q4 25
$96.2M
Q3 25
Q2 25
Q1 25
Q4 24
$197.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
OM
OM
SMID
SMID
Q4 25
$127.0M
$54.3M
Q3 25
$142.4M
$52.1M
Q2 25
$154.8M
$49.2M
Q1 25
$169.9M
$45.1M
Q4 24
$26.8M
$41.7M
Q3 24
$47.8M
$40.3M
Q2 24
$68.6M
$37.2M
Q1 24
$93.2M
$35.3M
Total Assets
OM
OM
SMID
SMID
Q4 25
$264.5M
$87.7M
Q3 25
$277.3M
$85.4M
Q2 25
$288.8M
$81.2K
Q1 25
$301.2M
$74.7M
Q4 24
$275.8M
$68.0M
Q3 24
$292.9M
$66.6M
Q2 24
$314.5M
$64.0M
Q1 24
$346.2M
$64.9M
Debt / Equity
OM
OM
SMID
SMID
Q4 25
0.76×
Q3 25
Q2 25
Q1 25
Q4 24
7.36×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OM
OM
SMID
SMID
Operating Cash FlowLast quarter
$-9.5M
Free Cash FlowOCF − Capex
$-9.7M
FCF MarginFCF / Revenue
-33.7%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-47.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OM
OM
SMID
SMID
Q4 25
$-9.5M
Q3 25
$-6.3M
$11.7M
Q2 25
$-4.8M
Q1 25
$-25.7M
$2.2M
Q4 24
$-16.5M
$-645.0K
Q3 24
$-20.6M
$3.9M
Q2 24
$-33.3M
$2.7M
Q1 24
$-45.9M
$-777.0K
Free Cash Flow
OM
OM
SMID
SMID
Q4 25
$-9.7M
Q3 25
$-6.5M
$6.3M
Q2 25
$-5.1M
Q1 25
$-25.8M
$1.6M
Q4 24
$-16.5M
$-1.3M
Q3 24
$-21.0M
$1.8M
Q2 24
$-33.5M
$998.0K
Q1 24
$-46.3M
$-2.6M
FCF Margin
OM
OM
SMID
SMID
Q4 25
-33.7%
Q3 25
-22.0%
29.5%
Q2 25
-16.3%
Q1 25
-86.7%
7.1%
Q4 24
-56.1%
-7.0%
Q3 24
-73.1%
7.8%
Q2 24
-122.2%
5.1%
Q1 24
-164.3%
-15.3%
Capex Intensity
OM
OM
SMID
SMID
Q4 25
0.8%
Q3 25
0.5%
25.1%
Q2 25
0.9%
Q1 25
0.4%
2.6%
Q4 24
0.1%
3.6%
Q3 24
1.4%
8.6%
Q2 24
0.4%
8.7%
Q1 24
1.3%
10.7%
Cash Conversion
OM
OM
SMID
SMID
Q4 25
Q3 25
4.07×
Q2 25
Q1 25
0.67×
Q4 24
-0.46×
Q3 24
1.23×
Q2 24
1.37×
Q1 24
-0.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

SMID
SMID

Product Sales$13.8M60%
Service Revenue$9.3M40%

Related Comparisons